CORVUS PHARMACEUTICALS INC's ticker is and the CUSIP is 221015950. A total of 2 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | -81.8% | 1,600 | -67.3% | 0.00% | – |
| Q2 2023 | $11 | +1000.0% | 4,900 | +345.5% | 0.00% | – |
| Q1 2023 | $1 | -96.7% | 1,100 | -96.9% | 0.00% | – |
| Q4 2022 | $30 | -99.9% | 35,400 | -4.1% | 0.00% | – |
| Q3 2022 | $30,000 | +150.0% | 36,900 | +188.3% | 0.00% | – |
| Q2 2022 | $12,000 | -61.3% | 12,800 | -33.3% | 0.00% | – |
| Q1 2022 | $31,000 | +93.8% | 19,200 | +186.6% | 0.00% | – |
| Q4 2021 | $16,000 | +220.0% | 6,700 | +252.6% | 0.00% | – |
| Q3 2021 | $5,000 | 0.0% | 1,900 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -79.2% | 1,900 | +2275.0% | 0.00% | – |
| Q1 2021 | $24,000 | +380.0% | 80 | +433.3% | 0.00% | – |
| Q4 2020 | $5,000 | – | 15 | +650.0% | 0.00% | – |
| Q1 2020 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 5,700 | $8,322 | 0.00% |
| SIMPLEX TRADING, LLC | 1,600 | $2 | 0.00% |